{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:56:18Z","timestamp":1790553378265,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57266-y","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:53:50Z","timestamp":1782795230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional classification systems and their association with botulinum toxin type a use in pediatric cerebral palsy"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9763-5912","authenticated-orcid":false,"given":"Duygu","family":"Kurtulu\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Basar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Kaleoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"57266_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/dmcn.12080","volume":"55","author":"M Oskoui","year":"2013","unstructured":"Oskoui, M., Coutinho, F., Dykeman, J., Jett\u00e9, N. & Pringsheim, T. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev. Med. Child. Neurol. 55, 509\u2013519 (2013).","journal-title":"Dev. Med. Child. Neurol."},{"key":"57266_CR2","first-page":"1","volume":"49","author":"P Rosenbaum","year":"2007","unstructured":"Rosenbaum, P., Paneth, N., Leviton, A., Goldstein, M. & Bax, M. The definition and classification of cerebral palsy. Dev. Med. Child. Neurol. 49, 1\u201344 (2007).","journal-title":"Dev. Med. Child. Neurol."},{"key":"57266_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1212\/WNL.0b013e3181cbcd2f","volume":"74","author":"MR Delgado","year":"2010","unstructured":"Delgado, M. R. et al. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Neurology 74, 336\u2013343 (2010).","journal-title":"Neurology"},{"key":"57266_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejpn.2009.09.005","volume":"14","author":"F Heinen","year":"2010","unstructured":"Heinen, F. et al. The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. Eur. J. Paediatr. Neurol. 14, 45\u201366 (2010).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"57266_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1017\/S0012162206001162","volume":"48","author":"AC Eliasson","year":"2006","unstructured":"Eliasson, A. C. et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev. Med. Child. Neurol. 48, 549\u2013554 (2006).","journal-title":"Dev. Med. Child. Neurol."},{"key":"57266_CR6","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1469-8749.2011.03996.x","volume":"53","author":"MJ Hidecker","year":"2011","unstructured":"Hidecker, M. J. et al. Developing and validating the Communication Function Classification System for individuals with cerebral palsy. Dev. Med. Child. Neurol. 53, 704\u2013710 (2011).","journal-title":"Dev. Med. Child. Neurol."},{"key":"57266_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1468-1331.2003.00582.x","volume":"10","author":"J S\u0142awek","year":"2003","unstructured":"S\u0142awek, J. & Klimont, L. Functional improvement in cerebral palsy patients treated with botulinum toxin A injections - preliminary results. Eur. J. Neurol. 10, 313\u2013317 (2003).","journal-title":"Eur. J. Neurol."},{"key":"57266_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.pediatrneurol.2006.09.003","volume":"35","author":"AI Dai","year":"2006","unstructured":"Dai, A. I. Botulinum toxin type A in the management of cerebral palsy: low or high dose? Pediatr. Neurol. 35, 445\u2013447 (2006).","journal-title":"Pediatr. Neurol."},{"key":"57266_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/adc.83.6.481","volume":"83","author":"T Ubhi","year":"2000","unstructured":"Ubhi, T., Bhakta, B. B., Ives, H. L., Allgar, V. & Roussounis, S. H. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch. Dis. Child. 83, 481\u2013487 (2000).","journal-title":"Arch. Dis. Child."},{"key":"57266_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/PHM.0000000000002533","volume":"104","author":"OZ Gresits","year":"2025","unstructured":"Gresits, O. Z. et al. Limited evidence of functional benefit after upper limb botulinum toxin treatment in children with cerebral palsy: systematic review and meta-analysis. Am. J. Phys. Med. Rehabil. 104, 108\u2013116 (2025).","journal-title":"Am. J. Phys. Med. Rehabil"},{"key":"57266_CR11","doi-asserted-by":"publisher","first-page":"103578","DOI":"10.1016\/j.otsr.2023.103578","volume":"110","author":"C Klein","year":"2024","unstructured":"Klein, C., Gouron, R. & Barbier, V. Effects of botulinum toxin injections in the upper limbs of children with cerebral palsy: A systematic review of the literature. Orthop. Traumatol. Surg. Res. 110, 103578 (2024).","journal-title":"Orthop. Traumatol. Surg. Res."},{"key":"57266_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/dmcn.15426","volume":"65","author":"J Hedberg-Graff","year":"2023","unstructured":"Hedberg-Graff, J., Granstr\u00f6m, F. & Krumlinde-Sundholm, L. Physical characteristics and upper-limb treatment with botulinum neurotoxin A in children with cerebral palsy: A population-based study. Dev. Med. Child. Neurol. 65, 571\u2013579 (2023).","journal-title":"Dev. Med. Child. Neurol."},{"key":"57266_CR13","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3390\/ijerph18041881","volume":"18","author":"EY Park","year":"2021","unstructured":"Park, E. Y. Stability of the Communication Function Classification System among children with cerebral palsy in South Korea. Int. J. Environ. Res. Public. Health. 18, 1881 (2021).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"57266_CR14","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/dmcn.14910","volume":"63","author":"D Piscitelli","year":"2021","unstructured":"Piscitelli, D., Ferrarello, F., Ugolini, A., Verola, S. & Pellicciari, L. Measurement properties of the Gross Motor Function Classification System, Gross Motor Function Classification System-Expanded & Revised, Manual Ability Classification System, and Communication Function Classification System in cerebral palsy: a systematic review with meta-analysis. Dev. Med. Child. Neurol. 63, 1251\u20131261 (2021).","journal-title":"Dev. Med. Child. Neurol."},{"key":"57266_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.25259\/JMSR_196_2024","volume":"9","author":"AK Bamaga","year":"2025","unstructured":"Bamaga, A. K. et al. Low- versus high-dose botulinum toxin type A injection for the treatment of upper limb spasticity in pediatric patients with cerebral palsy: A systematic review and meta-analysis. J. Musculoskelet. Surg. Res. 9, 4\u201310 (2025).","journal-title":"J. Musculoskelet. Surg. Res."},{"key":"57266_CR16","doi-asserted-by":"publisher","first-page":"jrm00349","DOI":"10.2340\/jrm.v54.2540","volume":"54","author":"J Carranza-Del R\u00edo","year":"2022","unstructured":"Carranza-Del R\u00edo, J. et al. Goal attainment after treatment with abobotulinumtoxina and a tailored home therapy programme in children with upper limb spasticity: descriptive, exploratory analysis of a large randomized, controlled study. J. Rehabil Med. 54, jrm00349 (2022).","journal-title":"J. Rehabil Med."},{"key":"57266_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11832-010-0246-x","volume":"4","author":"G Molenaers","year":"2010","unstructured":"Molenaers, G., Van Campenhout, A., Fagard, K., De Cat, J. & Desloovere, K. The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb. J. Child. Orthop. 4, 183\u2013195 (2010).","journal-title":"J. Child. Orthop."},{"key":"57266_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejpn.2024.02.017","volume":"49","author":"E Papageorgiou","year":"2024","unstructured":"Papageorgiou, E. et al. Botulinum neurotoxin type A responders among children with spastic cerebral palsy: Pattern-specific effects. Eur. J. Paediatr. Neurol. 49, 131\u2013140 (2024).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"57266_CR19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1469-8749.2008.03089.x","volume":"50","author":"RJ Palisano","year":"2008","unstructured":"Palisano, R. J., Rosenbaum, P., Bartlett, D. & Livingston, M. H. Content validity of the expanded and revised Gross Motor Function Classification System. Dev. Med. Child. Neurol. 50, 744\u2013750 (2008).","journal-title":"Dev. Med. Child. Neurol."},{"key":"57266_CR20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/dmcn.12246","volume":"55","author":"I Novak","year":"2013","unstructured":"Novak, I. et al. A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev. Med. Child. Neurol. 55, 885\u2013910 (2013).","journal-title":"Dev. Med. Child. Neurol."},{"key":"57266_CR21","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1542\/peds.2013-0675","volume":"133","author":"L Sakzewski","year":"2014","unstructured":"Sakzewski, L., Ziviani, J. & Boyd, R. N. Efficacy of upper limb therapies for unilateral cerebral palsy: a meta-analysis. Pediatrics 133, e175\u2013e204 (2014).","journal-title":"Pediatrics"},{"key":"57266_CR22","doi-asserted-by":"publisher","first-page":"e2023093","DOI":"10.1590\/1984-0462\/2024\/42\/2023093","volume":"42","author":"SR Dorf","year":"2024","unstructured":"Dorf, S. R., Fonseca, R. A., Sztajnbok, F. R., Oliveira, T. R. D. & Basttistella, L. R. The state of the art in therapeutic administration of botulinum toxin in children with cerebral palsy: an integrative review. Rev. Paul Pediatr. 42, e2023093 (2024).","journal-title":"Rev. Paul Pediatr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57266-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57266-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57266-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:14:36Z","timestamp":1790550876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57266-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57266"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57266-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29976"}}